Buy AMP-5 Injection 20ml Online

AMP-5 Injection 20ml for Equine Veterinary Support

AMP-5 Injection 20ml is a veterinary injectable formulation containing adenosine-5-monophosphate at 200 mg/mL. The product is marketed for veterinary use in horses and is described by the manufacturer as a vasodilator associated with circulation to cardiac and skeletal muscle. The official Ceva Australia product page identifies the presentation as a 20 mL sterile injection and specifies that it is for intramuscular administration only.

AMP-5 is primarily researched in an equine veterinary context because of its relationship to vascular function and situations involving substantial physical exertion. Manufacturer information describes applications including support around severe cardiac load and muscle cramping or “tying up.”

Because AMP-5 is an injectable veterinary product, product-specific instructions, local regulatory requirements, and professional veterinary advice should always be considered before use. The regulatory classification can also differ between jurisdictions; for example, an Australian veterinary supplier currently lists AMP-5 as an S4 prescription product, while the manufacturer page identifies the Australian injection as available for general sale under APVMA registration 51114.

---

What Is AMP-5 Injection 20ml?

AMP-5 Injection 20ml is a veterinary injectable containing adenosine-5-monophosphate (AMP) at 200 mg/mL. It is associated primarily with equine veterinary applications involving vascular and muscle support.

The manufacturer describes AMP-5 as producing vasodilation involving cardiac and skeletal muscle circulation. Its listed indications include coronary vasodilation in anticipation of substantial cardiac load in athletic animals, treatment of myocardial oxygen deficit associated with performance-linked ECG changes, and prevention of muscle cramping or “tying up.”

The product is supplied as a 20 mL sterile injection. Importantly, Ceva’s product information specifically states that the injection must only be administered intramuscularly and warns against intravenous administration because of the potential for a rapid and profound decrease in blood pressure, potentially resulting in collapse or death.

That warning makes correct product identification and professional handling especially important when purchasing AMP-5 Injection online.

---

AMP-5 Injection Overview

The manufacturer’s product page identifies AMP-5 Injection as a 20 mL sterile injection and lists adenosine-5-monophosphate at 200 mg/mL as its composition.

Some online listings provide different species information or administration details, so the current package label should always be treated as the definitive source for the particular product being supplied.

---

Active Ingredient: Adenosine-5-Monophosphate

The active constituent in AMP-5 Injection is adenosine-5-monophosphate (AMP) at a concentration of 200 mg/mL.

Adenosine-related compounds have recognized roles in physiological signaling, and veterinary product information describes AMP-5 specifically in terms of its vasodilatory action.

For an equine product page, it is useful to distinguish the active ingredient from broad marketing descriptions. AMP-5 should not simply be characterized as an ordinary vitamin injection or general nutritional supplement. It is an injectable veterinary formulation with a defined pharmacological purpose.

This distinction is particularly relevant for horse owners, trainers, veterinary professionals, and buyers who are comparing AMP-5 with amino-acid, vitamin, electrolyte, or other nutritional-support products.

---

Key Features of AMP-5 Injection 20ml

20 mL Sterile Injection

AMP-5 is supplied as a 20 mL sterile injectable presentation. The manufacturer specifically identifies this presentation on its product information.

200 mg/mL Adenosine-5-Monophosphate

The formulation contains adenosine-5-monophosphate at 200 mg/mL, providing a clearly defined active constituent and concentration.

Veterinary Formulation

AMP-5 is formulated for veterinary use rather than human use. Product information focuses particularly on horses and veterinary management associated with circulation, exertion, and muscle cramping.

Vasodilatory Veterinary Action

Manufacturer information describes AMP-5 as producing vasodilation involving cardiac and skeletal muscle circulation.

Specific Administration Requirements

The manufacturer’s warning that AMP-5 injection should not be administered intravenously is one of the most important product-specific considerations.

---

Veterinary and Equine Context

AMP-5 has a particularly strong association with equine veterinary use.

The manufacturer’s equine product information describes the product in relation to:

• Coronary vasodilation
• Cardiac load associated with strenuous activity
• Myocardial oxygen deficit
• Performance-associated ECG changes
• Muscle cramping
• “Tying up” prevention

The product also appears in veterinary catalogs specifically under equine products. Ceva’s current equine product listing includes AMP 5 Injection alongside other veterinary products intended for horses.

For horse owners, however, a product’s association with athletic horses does not mean that it should be used routinely or independently. Cardiovascular abnormalities, exercise intolerance, muscle disorders, and tying-up episodes can have different causes and may require veterinary investigation.

---

AMP-5 and Circulatory Support

AMP-5 is described by the manufacturer as a potent vasodilator affecting cardiac and skeletal muscle circulation. The intended veterinary rationale is that increased circulation can support oxygen and nutrient delivery to working tissues and assist with removal of metabolic by-products.

This information helps explain why AMP-5 appears in equine veterinary contexts involving strenuous exercise.

However, descriptions of physiological action should not be interpreted as a guarantee of improved athletic performance. The response of an individual horse depends on its health, conditioning, workload, underlying conditions, and many other factors.

Where cardiovascular concerns are present, professional veterinary assessment remains important.

---

AMP-5 and Muscle Cramping

One of the manufacturer’s listed indications for AMP-5 is muscle cramp and prevention of “tying up.”

“Tying up” describes an important group of equine muscle disorders associated with exercise and muscle damage. It is not simply ordinary post-exercise soreness.

A horse showing signs such as severe muscle stiffness, reluctance to move, sweating, muscle tremors, or other significant abnormalities during or after exercise should be evaluated appropriately by a veterinarian.

AMP-5 should therefore not be marketed as a universal solution for every case of muscle cramping. The underlying cause of an episode needs to be considered.

---

AMP-5 for Athletic Horses

AMP-5 is frequently associated with athletic horses because the manufacturer’s listed veterinary indications include cardiac load associated with strenuous activity and exercise-related muscle cramping.

This makes accurate product information especially important for owners and veterinary professionals involved with competition horses.

Athletic horses can be subject to additional medication and prohibited-substance rules. A product that is legally available for veterinary use in one jurisdiction may have different restrictions in another, and competition organizations can impose their own rules.

For this reason, horse owners should check the current rules of their governing competition organization before using AMP-5 in a competition horse.

---

Product Details

Product Name

AMP-5 Injection 20ml

Active Ingredient

Adenosine-5-monophosphate

Concentration

200 mg/mL

Product Form

Sterile injectable solution.

Pack Size

20 mL

Intended Veterinary Context

Primarily associated with equine veterinary use, particularly in relation to vascular support, cardiac load, and muscle cramping.

Manufacturer Information

Ceva Animal Health Australia lists AMP 5 Injection among its veterinary products and identifies the composition as adenosine-5-monophosphate 200 mg/mL.

---

Safety and Important Precautions

AMP-5 requires particular attention to administration safety.

Intravenous Administration Warning

The manufacturer’s most important warning is that AMP-5 Injection must not be administered intravenously. Ceva states that intravenous administration can produce a profound rapid decrease in blood pressure and may result in collapse or death.

This is a critical distinction between AMP-5 and products for which intravenous administration may be appropriate.

The product should therefore only be administered according to the current official product information and appropriate veterinary direction.

Veterinary Assessment

Horses experiencing recurring muscle cramping, exercise intolerance, abnormal ECG findings, collapse, or unusual fatigue require appropriate veterinary assessment rather than simply being treated according to an online product description.

Product Integrity

Before use, check:

• Product name
• Active ingredient
• Concentration
• Package size
• Expiration date
• Container integrity
• Batch or lot information
• Current label instructions

Do not use a veterinary injectable if the packaging appears damaged or the product is expired.

---

Storage and Handling

Ceva’s product information states that AMP-5 Injection should be stored below 25°C under air-conditioning conditions.

The manufacturer’s information should be followed for the particular product being purchased.

Good handling practices include:

• Keep the product in its original packaging.
• Store according to the current label.
• Avoid inappropriate heat exposure.
• Check the expiration date before use.
• Maintain appropriate sterile handling.
• Keep veterinary medicines away from children and unauthorized users.
• Dispose of unused product and packaging according to applicable veterinary and pharmaceutical requirements.

The official product information also states that the contents of the vial should be used within the specified period after first broaching the vial and that unused material should be discarded.

---

Competition and Regulatory Considerations

AMP-5 is closely associated with athletic-horse use, so competition rules deserve particular attention.

The fact that a veterinary product is commercially available does not automatically mean that its use is permitted under every competition organization’s medication rules.

Rules can differ by:

• Competition organization
• Country
• Racing authority
• Discipline
• Event
• Testing program
• Current prohibited-substance list

Owners and trainers should consult the applicable governing body before administering any product to a competition horse.

Regulatory status can also vary between countries. For example, the Australian manufacturer page identifies AMP-5 Injection under APVMA registration 51114 and describes it as available for general sale, while another Australian veterinary supplier currently categorizes the product as an S4 prescription product.

This difference demonstrates why buyers should verify the requirements applicable to their own jurisdiction rather than relying on an overseas product listing.

There is also documented evidence that AMP-5 was among veterinary medicines seized by UK authorities after being imported from Australia because the products were not authorized UK veterinary medicines.

For international purchasers, checking import and veterinary-medicine requirements before ordering is therefore important.

---

Purchasing Considerations

When purchasing AMP-5 Injection 20ml online, buyers should look beyond the product name alone.

Confirm the Product

Make sure the listing identifies:

• AMP-5 Injection
• 20 mL presentation
• Adenosine-5-monophosphate
• 200 mg/mL concentration

Check the Packaging

Look for intact packaging, appropriate labeling, lot information, and expiration information.

Consider the Destination

Veterinary medicines can have different legal classifications and import requirements in different countries. A product available in Australia may not be authorized for sale or importation in another country. The UK seizure notice involving AMP-5 illustrates this issue.

Consider Competition Rules

If the horse participates in racing or organized competition, verify the current medication rules before use.

Purchase From an Appropriate Veterinary Supplier

Product information should be clear and should not rely on unsupported promises about performance, safety, or guaranteed results.

---

Where To Buy AMP-5 Injection 20ml Online

If you are researching where to buy AMP-5 Injection 20ml online, World Equine Vet provides a dedicated product listing where customers can review the product and available purchasing information.

AMP-5 is an injectable veterinary product, so buyers should confirm the exact presentation, concentration, labeling, storage requirements, and applicable regulatory conditions before ordering.

International availability may vary. Veterinary-medicine importation requirements differ between countries, and a product that is legally supplied in one market may require authorization or may not be authorized in another. The UK Veterinary Medicines Directorate, for example, has documented the seizure of AMP-5 imported from Australia because it was not authorized as a UK veterinary medicine.

World Equine Vet should therefore be used as a source of product and purchasing information rather than as a substitute for local veterinary or regulatory advice.

---

Frequently Asked Questions

What is AMP-5 Injection 20ml?

AMP-5 Injection 20ml is a veterinary injectable containing adenosine-5-monophosphate at 200 mg/mL. It is primarily associated with equine veterinary applications involving vasodilation, cardiac load, and muscle cramping.

What is the active ingredient in AMP-5?

The active constituent is adenosine-5-monophosphate, listed at 200 mg/mL.

What size is AMP-5 Injection?

The manufacturer identifies AMP-5 Injection as a 20 mL sterile injection.

Is AMP-5 used in horses?

Yes. AMP-5 is specifically listed by Ceva among its equine veterinary products, with product information describing applications involving cardiac load and muscle cramping in horses.

What is AMP-5 used for in horses?

The manufacturer’s listed indications include coronary vasodilation associated with severe cardiac load, myocardial oxygen deficit associated with performance-linked ECG changes, and prevention of muscle cramping or “tying up.”

Can AMP-5 Injection be given intravenously?

No. The manufacturer specifically warns that AMP-5 Injection must not be administered intravenously because this may cause a profound rapid drop in blood pressure, collapse, and potentially death.

How should AMP-5 be administered?

The manufacturer’s product information specifies intramuscular administration for the injection. Because this is an injectable veterinary medicine, administration should follow the current product label and appropriate professional veterinary direction.

How should AMP-5 be stored?

The manufacturer states that the injection should be stored below 25°C under air-conditioning conditions. Always follow the storage information on the current product label.

Is AMP-5 a vitamin or amino-acid supplement?

No. Although it may appear alongside nutritional and performance-support products, AMP-5 is an injectable formulation containing adenosine-5-monophosphate and is described primarily in terms of its vasodilatory veterinary action.

Is AMP-5 suitable for competition horses?

AMP-5 is associated with athletic-horse veterinary use, but competition rules vary. Owners should check the current medication and prohibited-substance rules of the relevant competition or racing organization before use.

Can AMP-5 be shipped internationally?

That depends on the destination. Veterinary medicines can be subject to import, registration, prescription, and customs requirements. Buyers should confirm local requirements before ordering.

Is AMP-5 available without a prescription?

The answer depends on the jurisdiction and product registration. The Australian manufacturer page identifies its AMP-5 Injection under APVMA registration 51114 and lists general-sale availability, while an Australian veterinary supplier currently categorizes AMP-5 as an S4 prescription product.

Is AMP-5 the same as ordinary adenosine?

No. The product is specifically formulated as adenosine-5-monophosphate 200 mg/mL. Buyers should not assume that different adenosine-containing products have the same formulation, indications, or administration requirements.

---

Final Summary

AMP-5 Injection 20ml is a specialized veterinary injectable containing adenosine-5-monophosphate 200 mg/mL. It is particularly associated with equine veterinary care and is described by the manufacturer in relation to vasodilation involving cardiac and skeletal muscle, severe cardiac load, myocardial oxygen deficit associated with ECG changes, and muscle cramping or “tying up.”

Its 20 mL sterile injectable presentation, defined active ingredient, and specific administration requirements make accurate product identification important when purchasing. Most importantly, the manufacturer expressly warns against intravenous administration because of the potential for a severe fall in blood pressure and collapse.

For horse owners and veterinary professionals, AMP-5 should be considered within the context of the individual horse’s health, veterinary assessment, local regulations, and—where applicable—competition medication rules.

For international orders, customers should also confirm that AMP-5 is authorized and legally importable in their destination country before purchasing.

AMP-5 produces marked coronary vasodilation and improved myocardial cell perfusion, and can be used effectively in anticipation of severe cardiac load in athletic animals, or in the treatment of myocardial oxygen deficit (as evidenced by by performance linked ECG changes). AMP-5 is indicated in conditions leading to muscle cramping and ‘tying up’.

Active constituents: Adenosine-5-monophosphate 200mg/mL

Dosage and administration:
Administer by intramuscular injection only.
Note: Intravenous administration will produce a profound fall in blood pressure, and possible ataxia and collapse

Give two injections; one 24 hours before strenuous exercise, and a second injection 4 – 6 hours prior to anticpated strenuous exercise, by the intramuscular route.

Horses: 2.5 mL/100 kg bodyweighth
Dogs: 0.5 mL/10 kg bodyweight.

AMP-5 Injection 20ml is a coronary and skeletal muscle vasodilator. AMP-5 Injection is used effectively in anticipation of severe cardiac and muscle exertion. AMP-5 is useful as an aid in the prevention of muscle cramping and ‘tying up’.

AMP-5 Injection 20ml  produces marked coronary vasodilation and improved myocardial cell perfusion, and can be used effectively in anticipation of severe cardiac load in athletic animals, or in the treatment of myocardial oxygen deficit (as evidenced by by performance linked ECG changes). AMP-5 is indicated in conditions leading to muscle cramping and ‘tying up’.

Active constituents: Adenosine-5-monophosphate 200mg/mL

Dosage and administration:
Administer by intramuscular injection only.
Note: Intravenous administration will produce a profound fall in blood pressure, and possible ataxia and collapse

Give two injections; one 24 hours before strenuous exercise, and a second injection 4 – 6 hours prior to anticpated strenuous exercise, by the intramuscular route.

Horses: 2.5 mL/100 kg bodyweight
Dogs: 0.5 mL/10 kg bodyweight.

AMP-5 Injection  is also available in paste formulation for oral administration.

 

AMP-5 Injection 20ml is a coronary and skeletal muscle vasodilator. AMP-5 Injection is used effectively in anticipation of severe cardiac and muscle exertion. AMP-5 is useful as an aid in the prevention of muscle cramping and ‘tying up’.

AMP-5 Injection 20ml  produces marked coronary vasodilation and improved myocardial cell perfusion, and can be used effectively in anticipation of severe cardiac load in athletic animals, or in the treatment of myocardial oxygen deficit (as evidenced by by performance linked ECG changes). AMP-5 is indicated in conditions leading to muscle cramping and ‘tying up’.

Active constituents: Adenosine-5-monophosphate 200mg/mL

Dosage and administration:
Administer by intramuscular injection only.
Note: Intravenous administration will produce a profound fall in blood pressure, and possible ataxia and collapse

Give two injections; one 24 hours before strenuous exercise, and a second injection 4 – 6 hours prior to anticpated strenuous exercise, by the intramuscular route.

Horses: 2.5 mL/100 kg bodyweight